Brief: Novavax Appoints Dr. Robert Walker As Executive Vice President And Head Of Research & Development
30/03/2026 15:03
March 30 (Reuters) - Novavax Inc NVAX.O: NOVAVAX APPOINTS DR. ROBERT WALKER AS EXECUTIVE VICE PRESIDENT AND HEAD OF RESEARCH & DEVELOPMENT Source text: ID:nPn5XntfJa Further company coverage: NVAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks